Magle Chemoswed Holding AB

MAGLE

SE0014401014

Pharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2026-07-13 pm EDT			5-day change	1st Jan Change
1.280 ^SEK	+26.73%		+28.00%	-92.73%

12:19pm	Magle Chemoswed Begins Written Procedure to Revise Terms of Existing Bonds	MT
01:40am	Magle Group To Restructure Debt	RE

Magle Chemoswed in Talks for New Financing

Published on 06/08/2026 at 01:30 am EDT

MT Newswires

Add MarketScreener to your sources

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Magle Chemoswed Holding AB

12:19pm	Magle Chemoswed Begins Written Procedure to Revise Terms of Existing Bonds	MT
01:40am	Magle Group To Restructure Debt	RE
Jul. 10	Magle Chemoswed Holding AB Resolves on Restructuring of Outstanding Debt and Capital Structure, Including Debt-For-Equity Swap, Issuance of Super Senior Bonds and Directed Share Issues	CI
Jun. 30	Magle Chemoswed Holding AB Enters into Agreement with Danske Bank Regarding Repayment Schedule and Agreement with the Bondholders Committee Regarding the Requirement for Additional Capital	CI
Jun. 30	Magle Chemoswed Holding AB Approves to Elect Tom Rönnlund as Ordinary Board Member	CI
Jun. 22	Magle Chemoswed Holding AB Announces Successful Completion of the Written Procedure in Relation to Its Senior Secured Bonds 2025/2028	CI
Jun. 08	Magle Chemoswed in Talks for New Financing	MT
Jun. 07	Magle Group Delays Earnings Results Release for the Annual Report 2025	CI
May. 31	Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
May. 27	Magle Chemoswed AB and Magle Chemoswed Holding AB Enters into Loan Facility Agreement of Up to SEK 60 Million	CI
May. 26	Magle Chemoswed Holding AB Approves to Elect Søren Skjold Mogensen as New Board Member, Effective 26 May 2026	CI
May. 08	Magle Chemoswed Holding AB Announces That Malin Malmsjö Declines Re-Election as Board Member	CI
May. 01	Magle Chemoswed Holding AB Announces Board Resignations, Effective May 1, 2026	CI
Apr. 23	Magle Chemoswed Holding AB Announces Successful Completion of Written Procedure in Relation to Its Senior Secured Bonds 2025/2028	CI
Mar. 27	Magle Chemoswed Holding AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Chart Magle Chemoswed Holding AB

Duration

Period

MAGLE: Dynamic Chart

Magle Chemoswed Holding AB is a Sweden-based company that conducts research, development and manufacturing in the fields of pharmaceutical chemistry and pharmaceutical technology. The Company's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

Employees

150

Sector

Pharmaceuticals

Calendar

Earnings release - Q2 2026

More about the company